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Summary Data were collected on subsequent primary cancers occurring in 194 individuals diagnosed with ampullary carcinoma during
1979-92 in the north western region of England, UK. Four cancers were identified compared with 6.62 expected (relative risk 0.60),
suggesting that individuals with ampullary carcinoma are not at increased risk of developing subsequent primary cancers.
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Certain studies ofpatients with carcinoma ofthe Ampulla ofVater
have suggested that such patients are at an increased risk ofsubse-
quently developing a second primary cancer (Schlippert et al,
1978; Robertson et al, 1988). In this population-based study, the
risk of developing subsequent primary cancers is investigated in
individuals with ampullary carcinoma.
MATERIALS AND METHODS
Cancers occurring in residents of the north western region of
England, UK, are reported to the North Western Regional Cancer
Registry (NWRCR), which covers a population of four million.
All cases of ampullary and periampullary carcinoma (ICD-9
156.2) diagnosed between 1 January 1979 and 31 December 1992
were identified on the computerized database held atthe NWRCR.
The database was then searched for subsequent cancers occurring
in the individuals identified.
As a basis for calculating the expected number ofcancers, inci-
dence rates of all malignant tumours (ICD-9 140-208) for each of
the years 1979-94 were obtained from the NWRCR. Person-years-
at-risk were measured from date of diagnosis of the ampullary
cancer up to 31 December 1996 oruntil date ofdeath, ifbefore this
date. Age group, sex and calendar-year-specific person-years-
at-risk were multiplied by the corresponding incidence rates to
produce the number of cancers that would have been expected to
occur under the assumption that general population incidence rates
in the North Western Region applied. Incidence rates for 1994 were
used for 1995 and 1996. The relative risk of developing a subse-
quentprimary cancer was then estimated by the ratio ofthe number
of cases observed to the expected number, and an approximate
confidence interval was constructed (Rothman and Boice, 1988).
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RESULTS
One hundred and ninety-four cases of ampullary carcinoma were
identified on the NWRCR database, and these patients were
selected as the study population. Ninety-seven (50%) patients
were female and 97 were male. The median age at diagnosis was
72 years (range 26-93 years). The median follow-up was 8.7
months with 90% of cases having died by the end ofthe follow-up
period.
Four patients developed a subsequent cancer compared with an
expected number of 6.62, giving a relative risk of 0.60 (Table 1).
One patient with squamous cell carcinoma ofthe skin and another
with breast cancer were diagnosed 3 and 5 weeks, respectively,
after the ampullary cancers.
DISCUSSION
Ampullary cancer is known to be part of several cancer-prone
syndromes, including familial adenomatous polyposis and
hereditary non-polyposis colorectal cancer (Mecklin et al, 1992;
Offerhaus et al, 1992). In this study, patients with ampullary carci-
noma were not found to be at an increased risk of developing
subsequent primary cancers; even the upper limit of the 95%
confidence interval was not consistent with a markedly increased
risk ofdeveloping a subsequent cancer.
Two of the subsequent cancers identified were diagnosed
shortly after the ampullary cancer, their diagnosis almost certainly
brought forward in time by increased medical supervision associ-
ated with management ofthe first tumour. It is unlikely that further
follow-up would have identified many more tumours, as 90% of
subjects had died by the end of the study period. A review of
hospital notes, as part of a related study, confirmed the Registry
diagnosis in 123 (95%) out of 129 patients for whom notes were
available; the remaining six individuals did not have ampullary
carcinoma. An analysis restricted to the 123 confirmed cases
found a relative risk ofdeveloping a subsequent cancer of0.45.
Only one other study, based on a hospital series of 43 cases,
compared the number of subsequent cancers in patients with
1232Secondcancers following ampullarycarcinoma 1233
Table 1 The relative risk of developing a subsequent primary cancer
Age at diagnosis of Site of subsequent primary Age at Observed Expected Relative 95% Confidence
ampullary cancer diagnosis number (0) number (E) risk (O/E) interval
(years) (years)
48 Ovary 51
59 Female breast 59 4 6.62 0.60 0.16-1.55
68 SCCa of skin 68
70 BCCb of skin 74
aSquamous cell carcinoma. bBasal cell carcinoma.
ampullary carcinoma with the number expected using population-
based incidence rates (Robertson et al, 1988). Four subsequent
and one synchronous tumours were found compared with 1.27
expected. As patients in hospital series are often not typical of all
patients with a given disease because of referral and selection
biases, our population-based series will probably provide a more
robust estimate of the risk of subsequent cancers for all patients
with ampullary carcinoma.
The results of this study suggest that patients with ampullary
carcinoma are not at an increased risk of developing subsequent
cancers and do not support the view that patients with this cancer
should be kept under close surveillance, in the absence ofspecific
indications, to diagnose subsequent cancers at an early stage.
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